Eldad Zacksenhaus
101 College Street
Toronto, ON, Canada
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer.
Journal: Cell reports
Published: November 05, 2025
TLR7 signature of tumour innervation reveals two distinct pathways of triple-negative breast cancer progression.
Journal: British journal of cancer
Published: September 19, 2025
Yuxingcao formula suppresses acute erythroleukemia through inhibition of AKT1 and FLI1.
Journal: Fitoterapia
Published: September 01, 2025
Vitamin D3 and its active form calcitriol suppress erythroleukemia through upregulation of CHAC1 and downregulation of NOTCH1.
Journal: Medical oncology (Northwood, London, England)
Published: January 16, 2025
The Astragalus Membranaceus Herb Attenuates Leukemia by Inhibiting the FLI1 Oncogene and Enhancing Anti-Tumor Immunity.
Journal: International journal of molecular sciences
Published: November 12, 2024
FLI1 Induces Plaque Psoriasis and Its Inhibition Attenuates Disease Progression.
Journal: Journal of inflammation research
Published: October 22, 2024
UM171 suppresses breast cancer progression by inducing KLF2.
Journal: Breast cancer research and treatment
Published: February 07, 2024
An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiation.
Journal: Molecular medicine reports
Published: December 08, 2023
Last Updated: 09/26/2026